Intellia Therapeutics, inc (NTLA) Q2 2021 Earnings Call Transcript
NTLA earnings call for the period ending June 30, 2021.
Intellia Therapeutics(NTLA)
Nasdaq Global Market
NTLA
$132.68
$1.85
1.4%
Price as of October 19, 2021, 4:00 p.m. ET
View Interactive NTLA Charts
Intellia Therapeutics, Inc. Common Stock
Interactive Chart
Compare NTLA Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
NTLA
Intellia Therapeutics
|
$132.68 | $10B | 407.7% | 937.5% |
|
ILMN |
$414.08 | $64B | 27.8% | 179.8% |
|
EXEL |
$21.50 | $7B | -5.6% | 85.0% |
|
GILD |
$66.90 | $83B | 13.6% | 7.1% |
|
BMY |
$57.59 | $127B | -3.3% | 32.5% |
News & Analysis: Intellia Therapeutics
The Fool has written over 100 articles on Intellia Therapeutics.
Why Shares of Intellia Therapeutics Are Jumping Today
More progress in the pipeline has investors bullish on the company's shares.
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are Exploding
It's a good time to be a gene-editing company.
Intellia Therapeutics' Next Hurdles After Its Positive Clinical Results
There are still some key unanswered questions for the biotech's promising gene-editing therapy.
Is It Too Late to Buy Intellia Therapeutics?
After skyrocketing 68% last week, will this stock keep running higher?
Here's What Drove These Stocks Higher This Week
The most exciting clinical trial data in the medical community has huge implications for Intellia, and its peers.
Why Intellia Therapeutics Was a Winner on Wednesday
The company is about to fatten its coffers significantly.
Can Intellia Therapeutics Turn Exciting Trial Results into Profits?
New proof-of-concept results are a big deal for the medical community, but what about for your portfolio?
Ignoring Monday's 2 Big Nasdaq Winners Could Cost You Serious Money
Find out why these stocks are climbing higher.
